MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 3 filers reported holding MYOVANT SCIENCES LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10,780,091 | +5290.0% | 399,855 | +2567.8% | 0.06% | +2800.0% |
| Q1 2022 | $200,000 | -39.4% | 14,988 | -29.2% | 0.00% | -33.3% |
| Q4 2021 | $330,000 | +56.4% | 21,179 | +106.5% | 0.00% | 0.0% |
| Q1 2021 | $211,000 | -66.1% | 10,255 | -76.8% | 0.00% | -66.7% |
| Q3 2020 | $622,000 | – | 44,296 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $71,647,000 | 83.05% |
| VR Adviser, LLC | 845,000 | $17,424,000 | 4.17% |
| Opaleye Management Inc. | 682,500 | $14,073,000 | 2.84% |
| Eversept Partners, LP | 760,551 | $15,682,562 | 2.15% |
| Cormorant Asset Management, LP | 2,500,000 | $51,550,000 | 1.97% |
| Ghost Tree Capital, LLC | 300,000 | $6,186,000 | 1.63% |
| Bellevue Group AG | 4,647,000 | $95,821,000 | 1.36% |
| Aristides Capital LLC | 67,000 | $1,382,000 | 1.04% |
| Amia Capital LLP | 27,070 | $558,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 150,000 | $3,093,000 | 0.33% |